Skip to main content
Egyptian Liver Journal

Table 5 Correlation between serum I-FABP and the posttreatment parameters in group 2 pre- and post-HCV treatment

From: Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients

Posttreatment parameters

Pre-treatment I-FABP level

Post-treatment I-FABP level

Pearson correlation

P -value

Pearson correlation

P -value

Bilirubin total

(0.3–1.2 mg/dl)

0.286

0.044

0.018

0.900

AST

(< 35 IU/ml)

0.006

0.967

0.047

0.748

ALT

(< 35 IU/ml)

0.100

0.489

0.195

0.176

FIB4

0.068

0.638

0.233

0.104

APRI

0.140

0.331

0.219

0.126

FibroScan

(kpa)

 − 0.066-

0.649

 − 0.070-

0.629

CAP

(dB/m)

 − 0.030-

0.834

 − 0.077-

0.594

Back to article page